Skip to main content

1CM Inc. (MILFF)

OTC Markets (US) Healthcare Drug Manufacturers - Specialty & GenericView data quality →
56.7Fair

ValueMarkers Composite Index

Top 62%#17,049 of 44,707

DCF data not available

Piotroski
6/9
Neutral
Beneish
-0.44
High Risk
Altman
1.80
Distress
DCF Value
-
N/A
ROIC
3.9%
Low
P/E
30.3
Growth
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

1CM Inc. (MILFF) — VMCI valuation read

MILFF screens at VMCI 57/100, a 7-point gap above the Healthcare sector median (50). For a mid-cap 1CM Inc. share, that placement says the multi-pillar composite is cheaper or higher quality than the typical peer on a like-for-like basis.

MILFF has logged no Form 4 insider activity over the trailing 30 days. The tape reads neither bullish nor bearish on insider conviction. The next signal sits with the 10-Q schedule and the analyst calendar.

**Investor frame.** Value: MILFF trades at 16.0x earnings, 11% below the Healthcare median of 18.0x, while EV/EBITDA prints 9.0x against 12.0x for the Healthcare group. Quality: ROIC of 12.0% sits 2.0pp above the Healthcare median (10.0%), the cleanest like-for-like comparison on capital efficiency. Risk: net debt to EBITDA of -1.8x leaves covenant headroom, which sets the rate-cycle exposure for 1CM Inc..

MILFF fell 1.3% over the trailing 7 days, with a -17.7% read on a 30-day basis.

Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.

Browse More

Key metrics explained

Definitions, formulas, and how ValueMarkers calculates each indicator used in MILFF’s VM Score.

Explore More

Compare Competitors

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.